The SYNZULA brand, founded in 2015 (United States), from 13 sister brands and 2214 competing brands. SYNZULA is a brand of Lexicon Pharmaceuticals, listed on the stock exchange of New York. The sector of SYNZULA is Biotechnology.

SYNZULA is a brand of Lexicon Pharmaceuticals (LXRX) Share price

Share price and profitability of the share Lexicon Pharmaceuticals (SYNZULA)

Buy Lexicon Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 2.19

Portfolio valuation
Lexicon Pharmaceuticals (SYNZULA) over 5 years* USD 0.87

Stock market history Lexicon Pharmaceuticals (SYNZULA)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more